Luke Walker

Insider Reports History

Location
Seattle, WA
Signature
/s/ Andrea Paul, attorney-in-fact for Luke Walker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Luke Walker:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Director Common Stock 144,284 $171,697 $1.19 17 Jun 2025 Direct
Context Therapeutics Inc. Director Stock Option (right to buy) 123,500 12 Jun 2025 Direct
Harpoon Therapeutics, Inc. Chief Medical Officer Common Stock 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. Chief Medical Officer Employee Stock Option (Right to Buy) 0 11 Mar 2024 Direct

Insider Reports Filed by Luke Walker

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:19
CNTX Context Therapeutics Inc. 12 Jun 2025 1 $0 4 Director 12 Jun 2025, 17:24
ZNTL Zentalis Pharmaceuticals, Inc. 31 Jan 2025 1 +$24,966 4 Director 04 Feb 2025, 16:43
CNTX Context Therapeutics Inc. 04 Sep 2024 1 $0 4 Director 05 Sep 2024, 08:04
CNTX Context Therapeutics Inc. 04 Sep 2024 0 $0 3 Director 05 Sep 2024, 08:01
ZNTL Zentalis Pharmaceuticals, Inc. 24 May 2024 1 $0 4 Director 29 May 2024, 07:34
ZNTL Zentalis Pharmaceuticals, Inc. 24 May 2024 0 $0 3 Director 29 May 2024, 07:33
HARP Harpoon Therapeutics, Inc. 11 Mar 2024 3 $0 4 Chief Medical Officer 11 Mar 2024, 17:25
HARP Harpoon Therapeutics, Inc. 07 Jan 2024 1 $0 4 Chief Medical Officer 09 Jan 2024, 16:30
HARP Harpoon Therapeutics, Inc. 26 Nov 2023 1 $0 4 Chief Medical Officer 28 Nov 2023, 16:32
HARP Harpoon Therapeutics, Inc. 24 Jan 2023 1 $0 4 Chief Medical Officer 26 Jan 2023, 15:05
HARP Harpoon Therapeutics, Inc. 03 Oct 2022 1 $0 4 Chief Medical Officer 04 Oct 2022, 16:12
HARP Harpoon Therapeutics, Inc. 03 Oct 2022 0 $0 3 Chief Medical Officer 04 Oct 2022, 16:09